Arena Pharmaceuticals (ARNA) News Today → Millionaire Investor makes surprising election prediction (From InvestorPlace) (Ad) Free ARNA Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative August 31, 2023 | uk.investing.comArwana Citramulia Tbk (ARNA)August 21, 2023 | foxnews.comMLS club places Bruce Arena on leave over probe into 'allegations of insensitive and inappropriate remarks'May 23, 2023 | bizjournals.comRNA startup launches with $300M, Merck partnershipMay 23, 2023 | seekingalpha.comLongboard Pharmaceuticals: Undervalued Arena Spin-Out Has 2 Data Catalysts Due In 2023May 6, 2023 | cnbc.comPfizer earnings and revenue top expectations despite Covid vaccine sales declineApril 25, 2023 | health.usnews.comArna L. DavidsonApril 12, 2023 | foxnews.comPortland, Maine, reopens basketball arena to migrantsMarch 17, 2023 | forbes.comIs Pfizer Stock Undervalued At $40?February 9, 2023 | benzinga.comArna Marketing Group Continues Investing in State-of-the-art Canon Inkjet Technology to Deliver "The Arna Advantage"February 8, 2023 | finance.yahoo.comArna Marketing Group Continues Investing in State-of-the-art Canon Inkjet Technology to Deliver “The Arna Advantage”February 6, 2023 | msn.comA DNA protein may be responsible for causing cancerous ‘stress balls’ in the body: U of S researchAugust 23, 2022 | thestreet.comObesity Drugs: The Road to PerditionAugust 9, 2022 | baystreet.caPfizer to Buy Global Blood TherapeuticsAugust 4, 2022 | forbes.comShould You Buy Pfizer Stock After An Upbeat Q2?June 29, 2022 | forbes.comShould You Buy, Sell, Or Hold Pfizer Stock At $52?May 3, 2022 | theglobeandmail.com7 Biotech Stocks With Key Catalysts in MarchMarch 11, 2022 | marketbeat.comTrading was temporarily halted for "ARNA" at 07:03 PM with a stated reason of "News pending."March 10, 2022 | seekingalpha.comPfizer confirms HSR waiting period for Arena Pharmaceuticals deal expiredMarch 7, 2022 | seekingalpha.comArena Pharma gains after report Pfizer deal will clear without HSR second requestFebruary 25, 2022 | seekingalpha.comArena Pharmaceuticals GAAP EPS of -$2.54 misses by $0.31February 24, 2022 | msn.comArena (ARNA) Q4 Loss Wider Than Expected, Etrasimod in FocusFebruary 23, 2022 | uk.finance.yahoo.comSFO opens criminal probe into collapse of Arena TelevisionFebruary 23, 2022 | finance.yahoo.comArena Reports Fourth Quarter and Full Year 2021 Financial Results and Key Program UpdatesFebruary 9, 2022 | finance.yahoo.comArena Pharmaceuticals to Release Fourth Quarter and Full-Year 2021 Financial Results and Provide Corporate Update on February 23February 9, 2022 | benzinga.comHC Wainwright & Co. Downgrades Arena Pharmaceuticals to Neutral, Lowers Price Target to $100February 9, 2022 | markets.businessinsider.comExpert Ratings For Arena PharmaceuticalsFebruary 9, 2022 | marketbeat.comHC Wainwright Reaffirms "Neutral" Rating for Arena Pharmaceuticals (NASDAQ:ARNA)HC Wainwright restated a "neutral" rating and set a $100.00 price target (down from $120.00) on shares of Arena Pharmaceuticals in a research note on Wednesday.February 8, 2022 | nasdaq.comNotable Tuesday Option Activity: ARNA, MSGE, POWWFebruary 6, 2022 | finance.yahoo.comDid The Smart Money Play Arena Pharmaceuticals, Inc. (ARNA) Correctly?February 2, 2022 | finance.yahoo.comIntegral Health Asset Management, LLC Buys McKesson Corp, Centene Corp, Abbott Laboratories,January 31, 2022 | finance.yahoo.comHavens Advisors Llc Buys BHP Group PLC, CyrusOne Inc, NeoPhotonics Corp, Sells , ,January 22, 2022 | msn.com3 Clinical Trials to Watch in the First Half of 2022January 18, 2022 | finance.yahoo.comArena (ARNA) Stock Up in 6 Months on PFE Merger Deal & PipelineJanuary 12, 2022 | marketbeat.comArena Pharmaceuticals (NASDAQ:ARNA) Upgraded to Buy by Zacks Investment ResearchZacks Investment Research raised shares of Arena Pharmaceuticals from a "hold" rating to a "buy" rating and set a $98.00 price objective for the company in a research note on Wednesday.January 8, 2022 | nasdaq.comArena Pharmaceuticals Inc Shares Close in on 52-Week High - Market MoverJanuary 7, 2022 | law360.comStockholder Sues To Block Pfizer's $6.7B Arena Pharma BuyJanuary 3, 2022 | fool.comIs Pfizer's Acquisition of Arena a Good Move for Investors?January 3, 2022 | finance.yahoo.comAre Options Traders Betting on a Big Move in Arena (ARNA) Stock?December 28, 2021 | marketbeat.comArena Pharmaceuticals, Inc. (NASDAQ:ARNA) Receives Consensus Rating of "Hold" from AnalystsShares of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) have received a consensus rating of "Hold" from the fifteen research firms that are currently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, nine have given a hold recommendationDecember 23, 2021 | finance.yahoo.comPfizer’s Arena Pharma deal may lead drug company to a cannabis-based treatmentDecember 22, 2021 | finance.yahoo.comShould You Buy Arena Pharmaceuticals, Inc. (ARNA) After Golden Cross?December 20, 2021 | marketbeat.comArena Pharmaceuticals (NASDAQ:ARNA) Stock Rating Lowered by Cantor FitzgeraldCantor Fitzgerald downgraded Arena Pharmaceuticals from an "overweight" rating to a "neutral" rating in a research report on Monday.December 16, 2021 | nasdaq.comPfizer: Arena Acquisition to Unlock New Growth OpportunitiesDecember 16, 2021 | finance.yahoo.comARENA MERGER INVESTIGATION: Halper Sadeh LLP Announces Investigation Into Whether The Sale Of Arena Pharmaceuticals, Inc. Is Fair To Shareholders; Investors Are Encouraged To Contact The Firm - ARNADecember 15, 2021 | seekingalpha.comAbivax: Potentially The Next Arena Pharmaceuticals, Most Ideal Big Pharma M&A Target In 2022December 14, 2021 | prnewswire.comArena Pharmaceuticals INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Arena Pharmaceuticals, Inc. - ARNADecember 14, 2021 | finance.yahoo.comPfizer Set to Acquire Arena Pharmaceuticals for $6.7 BillionDecember 14, 2021 | markets.businessinsider.comWhat 6 Analyst Ratings Have To Say About Arena PharmaceuticalsDecember 14, 2021 | finance.yahoo.comPfizer (PFE) to Buy Arena, Boost Immuno-Inflammatory PipelineDecember 14, 2021 | finance.yahoo.comDoes PFE, ARNA Deal Signal Robust Pharma M&A Activity in 2022? Get Arena Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ARNA and its competitors with MarketBeat's FREE daily newsletter. Email Address [FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks (Ad)Are you monitoring 13,217 cryptocurrencies everyday? If not, you could miss the ONE that can make you wealthy beyond your wildest dreams. You see, while Bitcoin and Ethereum steal all the headlines… It’s often the cryptos flying under the radar that turn small stakes into life-changing windfalls. Claim your free seat by clicking here now. ARNA Media Mentions By Week ARNA Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ARNA News Sentiment▼0.000.49▲Average Medical News Sentiment ARNA News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ARNA Articles This Week▼00▲ARNA Articles Average Week Get Arena Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ARNA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Ionis Pharmaceuticals News Madrigal Pharmaceuticals News Alkermes News Amicus Therapeutics News PTC Therapeutics News Geron News Deciphera Pharmaceuticals News Sage Therapeutics News United Therapeutics News FibroGen News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ARNA) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaProtect Your Bank Account Before It’s Too LateWeiss RatingsHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”InvestorPlaceMissed NVDA? Buy this AI stock NOWChaikin AnalyticsUrgent Nvidia WarningAltimetryForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressI’m afraid WWIII is a very real possibility Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arena Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
